Ausgabe 3/2015
Inhalt (22 Artikel)
The predictive and prognostic role of phosphatase phosphoinositol-3 (PI3) kinase (PIK3CA) mutation in HER2-positive breast cancer receiving HER2-targeted therapy: a meta-analysis
Ezzeldin M. Ibrahim, Ghieth A. Kazkaz, Mubarak M. Al-Mansour, Meteb E. Al-Foheidi
Development and validation of the Female Sexual Function Index adaptation for breast cancer patients (FSFI-BC)
Iris Bartula, Kerry A. Sherman
Role of epithelial–mesenchymal transition markers in triple-negative breast cancer
Sai Yin Cheung, Yvonne Jia Yu Boey, Valerie Cui Yun Koh, Aye Aye Thike, Jeffrey Chun Tatt Lim, Jabed Iqbal, Puay Hoon Tan
Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer
Amanda J. Schech, Preeti Shah, Stephen Yu, Gauri J. Sabnis, Olga Goloubeva, Paula Rosenblatt, Armina Kazi, Saranya Chumsri, Angela Brodie
Fat/water ratios measured with diffuse reflectance spectroscopy to detect breast tumor boundaries
L. L. de Boer, B. G. Molenkamp, T. M. Bydlon, B. H. W. Hendriks, J. Wesseling, H. J. C. M. Sterenborg, T. J. M. Ruers
TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis
Susan M. Perkins, Casey Bales, Tudor Vladislav, Sandra Althouse, Kathy D. Miller, George Sandusky, Sunil Badve, Harikrishna Nakshatri
In vitro and in vivo studies of the combination of IGF1R inhibitor figitumumab (CP-751,871) with HER2 inhibitors trastuzumab and neratinib
Ashok K. Chakraborty, Cynthia Zerillo, Michael P. DiGiovanna
Interaction between smoking history and gene expression levels impacts survival of breast cancer patients
Sarah A. Andres, Katie E. Bickett, Mohammad A. Alatoum, Theodore S. Kalbfleisch, Guy N. Brock, James L. Wittliff
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer
Denise A. Yardley, Dianna L. Shipley, Nancy W. Peacock, Mythili Shastry, Rajiv Midha, Victor M. Priego, John D. Hainsworth
A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy
Emilie Le Rhun, Xavier Delbeuck, Claudia Lefeuvre-Plesse, Andrew Kramar, Emilie Skrobala, Florence Pasquier, Jacques Bonneterre
Does psychodynamic short-term psychotherapy for depressed breast cancer patients also improve fatigue? Results from a randomized controlled trial
Gregor Weißflog, Elmar Brähler, Katja Leuteritz, Yvette Barthel, Susanne Kuhnt, Jörg Wiltink, Rüdiger Zwerenz, Manfred E. Beutel
Does internal mammary node irradiation affect treatment outcome in clinical stage II–III breast cancer patients receiving neoadjuv ant chemotherapy?
Kyung Hwan Kim, Jae Myoung Noh, Yong Bae Kim, Jee Suk Chang, Ki Chang Keum, Seung Jae Huh, Doo Ho Choi, Won Park, Chang-Ok Suh
Prognostic significance of tumor subtypes in male breast cancer: a population-based study
José Pablo Leone, Julieta Leone, Ariel Osvaldo Zwenger, Julián Iturbe, Carlos Teodoro Vallejo, Bernardo Amadeo Leone
Decision-making impact on adjuvant chemotherapy allocation in early node-negative breast cancer with a 21-gene assay: systematic review and meta-analysis
Federico Augustovski, Natalie Soto, Joaquín Caporale, Lucas Gonzalez, Luz Gibbons, Agustín Ciapponi
Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
Annemieke Witteveen, Ingrid M. H. Vliegen, Gabe S. Sonke, Joost M. Klaase, Maarten J. IJzerman, Sabine Siesling
Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors
Adetunji T. Toriola, Jingxia Liu, Patricia A. Ganz, Graham A. Colditz, Lin Yang, Sonya Izadi, Michael J. Naughton, Anna L. Schwartz, Kathleen Y. Wolin
Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7–9 years after surgery: a nationwide prospective study of women treated for primary breast cancer
M Johannsen, S Christensen, R Zachariae, AB Jensen
Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
Boyoung Park, James G. Dowty, Choonghyun Ahn, Aung K. Win, Sung-Won Kim, Min Hyuk Lee, Jong Won Lee, Eunyoung Kang, John L. Hopper, Sue K. Park
The prognostic impact of age in different molecular subtypes of breast cancer
Cornelia Liedtke, Achim Rody, Oleg Gluz, Kristin Baumann, Daniel Beyer, Eva-Beatrice Kohls, Kerstin Lausen, Lars Hanker, Uwe Holtrich, Sven Becker, Thomas Karn
Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study
Danbee Kang, Im-Ryung Kim, Young Hyuck Im, Yeon Hee Park, Jin Seok Ahn, Jeong Eon Lee, Seok Jin Nam, Hyeokgon Park, Eunjoo Kim, Hae Kwang Lee, Dong-Youn Lee, Juhee Cho
Impact of carpal tunnel syndrome surgery on women with breast cancer-related lymphedema
Neetish Gunnoo, Michel Ebelin, Maria Arrault, Stéphane Vignes
Gene signature model for breast cancer risk prediction for women with sclerosing adenosis
Amy C. Degnim, Aziza Nassar, Melody Stallings-Mann, S. Keith Anderson, Ann L. Oberg, Robert A. Vierkant, Ryan D. Frank, Chen Wang, Stacey J. Winham, Marlene H. Frost, Lynn C. Hartmann, Daniel W. Visscher, Derek C. Radisky